CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Comparison of Repaglinide and Gliclazide for the Treatment of Type 2 Diabetes
Cheol Young Park, Young Seol Kim, Hyun Chul Lee, Hak Chul Jang
J Korean Diabetes. 2001;2(4):306-316.

Excel Download

Comparison of daytime 12-hour metabolic profiles after treatment with repaglinide and gliclazide in type 2 diabetes
Practical Diabetes. 2013;30(1):27-32   Crossref logo
Link1 Link2

Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study
Diabetic Medicine. 2001;18(5):395-401   Crossref logo
Link1 Link2 Link3

Comparison of repaglinide vs. gliclazide in combination with bedtime NPH insulin in patients with Type 2 diabetes inadequately controlled with oral hypoglycaemic agents
Diabetic Medicine. 2003;20(11):935-941   Crossref logo
Link1 Link2

P-8-4 Comparison of b-cell function after long-term treatment with insulin, insulin plus gliclazide and gliclazide in NIDDM-model rats
Diabetes Research and Clinical Practice. 1987;3:S81   Crossref logo
Link1 Link2

Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting
Diabetes Research and Clinical Practice. 2002;58(1):45-53   Crossref logo
Link1 Link2

Repaglinide: a new short-acting insulinotropic agent for the treatment of Type 2 diabetes
European Journal of Clinical Investigation. 1999;29(S2):30-37   Crossref logo
Link1 Link2 Link3

Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes
Diabetes, Obesity and Metabolism. 2008;080520205432340-???   Crossref logo
Link1 Link2

Efficacy and safety of repaglinide vs nateglinide for treatment of Japanese patients with type 2 diabetes mellitus
Journal of Diabetes Investigation. 2011;3(3):302-308   Crossref logo
Link1 Link2

Comparison of glycaemic control and cardiovascular risk profile in patients with type 2 diabetes during treatment with either repaglinide or metformin
Diabetes Research and Clinical Practice. 2003;60(3):161-169   Crossref logo
Link1 Link2

Cardiovascular effects of treatment of type 2 diabetes with pioglitazone, metformin and gliclazide
International Journal of Clinical Practice. 2004;58(9):833-837   Crossref logo
Link1 Link2